Clinical Trials Logo

Clinical Trial Summary

Within-subject, double-blind, placebo-controlled examination of opioid abuse potential in healthy individuals as a function of A118G SNP on the OPRM1 gene.


Clinical Trial Description

Participants completed a 5-day, within-subject, double-blind, placebo-controlled, randomized, human laboratory abuse potential trial. Healthy individuals were admitted to a residential research unit for 5 consecutive days. Blood samples were drawn for genome wide analyses using the Global Screening Array on day 1. Participants were administered an oral dose of the opioid hydromorphone (4mg) on day 2 of the study. Persons who did not evidence strong agonist effects then proceeded into the randomized period wherein they received 0mg, 2mg, and 8mg of oral hydromorphone on the remaining three study days. The order of dosing was randomized, with only 1 dose administered per day and all participants receiving 1 exposure to each dose. Outcomes were standard human abuse potential metrics, including self-reported drug effects and feeling high. Data were analyzed as a function of the A118SNP on the OPRM1 gene that codes for the mu opioid receptor. The overall aim was to determine whether signal for abuse potential among persons with no history of opioid misuse was associated with genotype. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02360371
Study type Interventional
Source Johns Hopkins University
Contact
Status Completed
Phase Phase 2
Start date April 2015
Completion date May 2021

See also
  Status Clinical Trial Phase
Completed NCT03429725 - Increasing Individualism and Collectivism N/A
Recruiting NCT03436264 - Identifying Neuroimaging Biomarkers, Demographic, Personality and Sensory Factors for Predicting Extreme Pain Responses to Various Experimental Pain Stimulations in Healthy Subjects
Completed NCT03585920 - The Influence of Fat Perception on Satiety From Consumption of Reduced Fat Snacks N/A
Completed NCT03798730 - Investigation of the Perception of Protein Fortified Foods and Beverages N/A
Completed NCT04308746 - Evaluating Attitudes Towards Organ Donation in the United States on MTurk N/A
Completed NCT04302779 - Investigating the Influence of Age and Saliva Flow on the Perception of Protein Fortified Foods and Beverages N/A
Completed NCT04507399 - Investigating Consumers Perception and Acceptance of Whey Beverages N/A
Completed NCT04869722 - Modifying Whey Protein Fortified Drinks and Foods N/A
Not yet recruiting NCT04326556 - Individual and Environmental Risk Factors for Unscheduled Hospitalizations of Elderly People N/A